实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (2): 207-210.doi: 10.3969/j.issn.1672-5069.2022.02.014

• 自身免疫性肝病 • 上一篇    下一篇

家族聚集性原发性胆汁性肝硬化患者临床特征分析

郑小勤, 徐辉, 李丽, 靳华, 汪晓军, 勾春燕   

  1. 100069 北京市 首都医科大学附属北京佑安医院中西医结合科
  • 收稿日期:2021-06-02 出版日期:2022-03-10 发布日期:2022-03-15
  • 通讯作者: 勾春燕,E-mail: syyxgcy@ccmu.edu.cn
  • 作者简介:郑小勤,女,35岁,硕士研究生,主治医师。主要从事传染性疾病的诊断和治疗研究。E-mail:xiaoqin.zheng@ccmu.edu.cn

Clinical features of patients with familial primary biliary cirrhosis

Zheng Xiaoqin, Xu Hui, Li Li, et al   

  1. Center for Integrated Chinese and Western Medicine Study, You'an Hospital, Capital Medical University, Beijing 100069, China
  • Received:2021-06-02 Online:2022-03-10 Published:2022-03-15

摘要: 目的 分析家族聚集性原发性胆汁性肝硬化(PBC)患者的临床特征,以提高对本病的认识。方法 纳入来自9个不同家族的17例PBC患者,采用回顾性分析方法总结其临床表现、影像学特点、病理学检查、治疗转归等临床资料。结果 在17例患者中,女性12例,男性5例,年龄为54.35±11.94岁;主要症状有乏力(64.7%),皮肤瘙痒(47.1%),黄疸(41.2%)和消化道出血(17.6%),部分无明显自觉症状(29.4%);血清ALP和GGT明显升高占76.4%,血清AMA/AMA-M2阳性率为88.2%;9例先证者与8例后证者均为一级亲属,其中姐妹(包括1对双胞胎姐妹)、姐弟关系占比为37.5%,父女、母女关系占比为12.5%;先证组年龄为57.75±10.38岁,包括1例(11.1%)无症状期、1例(11.1%)症状期和7例(77.8%)失代偿期PBC,而后证组年龄为47.63±7.19岁,包括1例(12.5%)临床前期、2例(25%)无症状期、3例(37.5%)症状期和2例(25%)失代偿期PBC;除1例临床前期外,其余16例均接受熊去氧胆酸治疗,平均随访5.2年,因肝衰竭死亡3例(包括1对双胞胎姐妹),其中先证者2例,后证者1例。结论 PBC发病有一定的家族聚集特点,主要累及先证者的一级亲属,最常见的为姐妹或姐弟关系。家族聚集性PBC无特殊的临床特点,容易识别。临床医生应重视PBC患者家族成员的早期筛查和早期治疗。

关键词: 原发性胆汁性肝硬化, 家族聚集, 临床特点, 诊断, 预后

Abstract: Objective The aim of this study was to summarize the clinical features of patients with familial primary biliary cirrhosis (PBC). Methods The clinical manifestations, imaging features, pathological findings, and clinical outcomes of 17 patients with PBC were collected from 9 different pedigrees, and were summarized by retrospective analysis. Results Out of the 17 patients with PBC, 12 were females and 5 males with the mean age of 54.35±11.94 years at presentation; the common clinical manifestations included fatigue (64.7%) , itching (47.1%), jaundice (41.2%) and gastrointestinal bleeding (17.6%), with 5 (29.4%) diagnosed without any obvious manifestations; the laboratory tests showed the elevation of serum ALP and GGT levels (76.4%), and serum AMA/AMA-M2 positive in 88.2%; the 8 diagnosed patients with PBC were the first-degree relatives of 9 probands, and among them, sister-sister pairs (including a pair of twins) and sister-brother pairs were 37.5% respectively, father-daughter, and mother-daughter were 12.5%; the mean age was 57.75±10.38 years in the probands, older than 47.63±7.19 years in the relative patients; in probands, the clinical stage included asymptomatic patient in 1 (11.1%), symptomatic patient in 1 (11.1%) and decompensated cirrhosis in 7 (77.8%), while in the diagnosed relatives included preclinical stage in 1 (12.5%), asymptomatic in 2 (25%), symptomatic in 3 (37.5%) and decompensated cirrhosis in 2 (25.0%); except for 1 patient in preclinical stage, 16 patients with PBC were treated with ursodeoxycholic acid, and during follow-up of 5.2 years, 3 patients including a pair of twin sisters progressed to death of liver failure, including 2 probands and 1 diagnosed relative. Conclusion The patients with PBC have some tendency of family clustering, mainly involved the first-degree relatives of the probands, with the most frequent probability of sister-sister pairs and sister-brother pairs. Since the clinical features of patients with familial PBC are similar to scattered PBC, it is convenient to recognize them. The clinicians should pay high attention to the early screening of the relatives of probands with PBC and give them early treatment once diagnosed.

Key words: Primary biliary cirrhosis, Family clustering, Clinical features, Diagnosis, Prognosis